Short answer
NOVANTA INC (NOVT) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Novanta announced fiscal Q3 2026 financial results for the quarter ended October 2, 2026.
NOVANTA INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Novanta announced fiscal Q3 2026 financial results for the quarter ended October 2, 2026
- Investor-relevant revenue, earnings and outlook details are in Exhibit 99.1, the accompanying earnings release
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $305.0M, up 23.1%, with 9.9% organic growth and $32.9M acquisition contribution
- Adjusted EBITDA $80.3M, up 38.3%, margin 26.3% versus 23.4%, signaling operating leverage
- GAAP net income fell to $2.0M from $10.7M, reflecting $23.1M restructuring, acquisition and related costs
- Riverpoint Medical acquisition drove major balance-sheet change: debt $829.8M, cash $149.2M, net debt $689.4M
- Full-year outlook maintained: revenue $1,135M-$1,140M, Adjusted EBITDA $274M-$277M, operating cash flow approximately $200M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NOVANTA INC 8-K filings
Get the next NOVT 8-K as it lands
Follow NOVT for push alerts, or ask the research agent what this filing means.